Verena Carola Obmann1,2, Rasim Boyacioglu1, Ananya Panda3, Irina Jaeger4, Lee Ponsky4, Mark Griswold1,5, and Vikas Gulani1,4,5
1Radiology, Case Western Reserve University, Cleveland, OH, United States, 2Diagnostic, Pediatric and Interventional Radiology, Inselspital, Bern, Switzerland, 3Radiology, Mayo Clinic, Rochester, MN, United States, 4Urology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States, 5Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States
Synopsis
It
has been shown that quantitative T1 relaxation times measured on T1 maps may
help differentiate transition zone (TZ) cancer from normal transition zone
(NTZ). However, T1 weighted images are not utilized for non-contrast detection
of prostate cancer. In this study, we explored scientific reasons why T1w
images have not been found to be of utility for this purpose. Fat suppressed
T1w 3D gradient echo (VIBE) sequence acquisition settings were adjusted based
on simulated acquisition parameters and our measured differences between cancer
and NTZ, to try to maximize differences in calculated signal between tumor
lesions and NTZ. The resulting contrast remains too subtle to utilize for
detection; though quantitative differences are readily measureable.
Introduction
Prostate
cancer is the commonest cancer in men and 25-45% of all prostate cancer are
located in the transition zone (TZ) (1). Traditionally, TZ lesions are characterized primarily on T2w images,
with secondary importance given to diffusion weighted imaging (DWI) or dynamic
contrast enhanced imaging in cases of suboptimal DWI (2).
Recent work with MR Fingerprinting has shown that T1 maps may differentiate
cancer from normal transition zone (NTZ) with TZ cancer having significantly
shorter T1 relaxation time than the NTZ (3). However clinically, non-contrast
T1w images are used almost exclusively for the exclusion of post-biopsy
hemorrhage and as a reference for DCE-MRI, but not for prostate cancer
detection. The goal of this work was to explore the scientific reason why T1w
images have not been found to be of utility in prostate cancer detection and
characterization, despite measureable T1 differences between cancer and normal
tissue.Methods
All
patients underwent a prostate MRI exam on a 3T scanner (Magnetom Verio, Siemens
Healthineers) including high-resolution T2w images, MR Fingerprinting, DWI with
ADC mapping and T1w gradient echo sequence (VIBE) with consecutive in-gantry
biopsy of suspicious lesions. After the MRF scan the relaxation times for the
suspicious lesions as well as for normal transition zone were measured for each
patient by drawing ROI on the individual T1maps while biopsy trajectory was
planned. These relaxation times were used to simulate expected signal and
signal differences between cancer and normal tissue for a wide range of
possible acquisition parameters with 3D FS Gradient Echo T1w imaging (VIBE on
the Siemens platform) (Figure 1). Based on this simulation, for each patient we
identified the optimal combination of TE, TR and flip angle that maximized the
signal difference between the lesion and NTZ. These settings were used to
adjust the VIBE acquisition. Due to time constraints and in order to not interfere
with the biopsy workflow, only one T1w VIBE acquisition per patient was
performed. In-gantry biopsy was performed as usual after the VIBE scan.Results
In
7 patients (median age 70 years, range 54-80 years) measured T1 and T2 relaxation
times demonstrated in Table 1. Mean T1 values for cancer lesions were 1408 ± 98
ms and 1782 ± 82 ms for NTZ. Table 1 also shows the calculated TR and FA for
each patient ranging between 4-5 ms (TR) and 5-32° (FA) and are demonstrated in
Table 1. Projected maximal percent signal differences ranged between -1 and
32%. To demonstrate this range of signal difference, Figure 1 visualizes the
simulation plots from two different patients with a result of 13 and 27% in
Figure 1A) and 1B), respectively. The acquired VIBE images resulting from
different combinations of TE, TR and FA did not reveal consistent detection of
the TZ lesions known from T2w, DWI images and/or T1/T2 maps from MRF. A patient
example with only subtle visual difference between tumor and NTZ is given in
Figure 2.Discussion
Although
calculated percent signal differences for transitional zone prostate cancer and
normal transition zone relaxation times were up to 32%, the resulting visual
contrast was very subtle (see, for example Figure 2). The lesion seen in right
anterior transition zone can be retrospectively identified based on T1w
contrast, but prospective detection with such a sequence would be difficult. As
demonstrated in prior studies (3), the overall difference in the TZ between T1
of cancer and NTZ is in the range of 200-300 ms (13-23%). This results in a
maximal absolute signal difference of 0.01 (considering initial magnetization
of 1 for both tissues in simulation). Even though percent differences are high,
actual contrast between normal and cancer tissues remains low. Each patient’s
T1w VIBE scan was optimized based on the same patient’s relaxation times and not
a group average or results from the literature. This approach ensures the
maximum possible contrast in a T1w scan. In the presence of noise, this may not
be large enough magnitude for visual detection.Conclusion
While
T1maps are a helpful tool in addition to T2 and ADC measurements to quantitatively
characterize transitional zone cancer, T1w images are not useful in the cancer detection
step, due to insufficient contrast between lesion and adjacent tissue.Acknowledgements
This
research was supported by NIH Grant 1R01CA208236-01A1 and Siemens Healthineers.References
1. Patel
V, Merrick GS, Allen ZA, Andreini H, Taubenslag W, Singh S, et al. The incidence of transition zone prostate cancer diagnosed by
transperineal template-guided mapping biopsy: implications for treatment
planning. Urology. 2011;77(5):1148-52.
2. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA,
Macura KJ, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015,
Version 2. European urology. 2016;69(1):16-40.
3. Panda A, Margevicius S,Jiang Y, et al.
MR Fingerprinting and
ADC Mapping for Characterization of Lesions in Transitional Zone of Prostate. Abstract 7514. Proc Int Soc
Mag Res Med 26:4502 (2018). Paris, France.